JAMDA
February 7, 2014
Showing 121 - 130 of 2567 results
JAMDA
November 16, 2017
Efficacy and Safety of Citalopram Compared With Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia
JAMDA
July 21, 2017
Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia
To assess efficacy and safety of citalopram compared to quetiapine and olanzapine for the treatment of agitation in patients with Alzheimer disease (AD).
JAMDA
February 26, 2020
Discontinuation of Antipsychotic Medication in Two Nursing Home Patients with Diagnosis of Schizophrenia
Caring for the Ages
September 29, 2022
Racial Disparities, Reimbursement for Care, and Quality of Life: Factors That May Influence the Prescribing of Antipsychotics for Minority Nursing Home Residents
Resolutions
D24 - Expand Access to Skilled Nursing Facility Services for Patients with Opioid Use Disorder (OUD)
Addiction Medicine
Explore our education, products, journal articles, and news specific to addiction medicine in post-acute and long-term care settings.
JAMDA
September 26, 2018
Quality Clinical Care in Nursing Facilities
Despite improvements in selected nursing facility (NF) quality measures such as reduction in antipsychotic use; local, state, and national initiatives; and regulatory incentives, the quality of clinical care delivered in this setting remains inconsistent. Herein, recommendations for overcoming barriers to ...
JAMDA
July 20, 2021
Racial Disparities in COVID-19 Vaccine Acceptance: Building Trust to Protect Nursing Home Staff and Residents
Vaccines are critical to protect both nursing home residents and staff from COVID-19, but some staff have expressed reservations about being vaccinated. In this brief report, we describe interventions that Genesis HealthCare—one of the largest US long-term care providers—implemented after recognizing midwa...
JAMDA
May 11, 2022